Log in
NASDAQ:TMDI

Titan Medical Stock Forecast, Price & News

$1.19
+0.20 (+20.20 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.99
Now: $1.19
$1.38
50-Day Range
$0.67
MA: $0.74
$0.99
52-Week Range
$0.12
Now: $1.19
$1.75
Volume5.57 million shs
Average Volume1.94 million shs
Market Capitalization$97.09 million
P/E RatioN/A
Dividend YieldN/A
Beta2.89
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.
Read More
Titan Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.73 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TMDI
CUSIPN/A
CIKN/A
Phone416-548-7522
Employees9

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.29) per share

Profitability

Net Income$-41,910,000.00

Miscellaneous

Market Cap$97.09 million
Next Earnings Date3/29/2021 (Estimated)
OptionableNot Optionable
$1.19
+0.20 (+20.20 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TMDI News and Ratings via Email

Sign-up to receive the latest news and ratings for TMDI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Titan Medical (NASDAQ:TMDI) Frequently Asked Questions

How has Titan Medical's stock price been impacted by Coronavirus (COVID-19)?

Titan Medical's stock was trading at $0.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TMDI stock has increased by 495.0% and is now trading at $1.19.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Titan Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Titan Medical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Titan Medical?

Wall Street analysts have given Titan Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Titan Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Titan Medical's next earnings date?

Titan Medical is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021.
View our earnings forecast for Titan Medical
.

What price target have analysts set for TMDI?

2 brokerages have issued 1-year target prices for Titan Medical's stock. Their forecasts range from $1.00 to $1.50. On average, they expect Titan Medical's stock price to reach $1.25 in the next twelve months. This suggests a possible upside of 5.0% from the stock's current price.
View analysts' price targets for Titan Medical
.

Who are some of Titan Medical's key competitors?

What other stocks do shareholders of Titan Medical own?

Who are Titan Medical's key executives?

Titan Medical's management team includes the following people:
  • Mr. David J. McNally, Pres, CEO & Chairman (Age 58, Pay $495k)
  • Mr. Sachin A. Sankholkar, VP of Marketing
  • Dr. Bruce Giles Wolff, Sr. Advisor & Member of Surgeon Advisory Board
  • Dr. Perry A. Genova, Sr. VP of R&D
  • Ms. Monique L. Delorme CPA, CA, Chief Financial Officer
  • Mr. Jasminder Brar, VP of Legal, IP & Strategic Initiatives, Corp. Sec. and Gen. Counsel

What is Titan Medical's stock symbol?

Titan Medical trades on the NASDAQ under the ticker symbol "TMDI."

Who are Titan Medical's major shareholders?

Titan Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Morgan Stanley (0.10%), JPMorgan Chase & Co. (0.06%) and Stratos Wealth Partners LTD. (0.04%).

Which institutional investors are buying Titan Medical stock?

TMDI stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, JPMorgan Chase & Co., and Stratos Wealth Partners LTD..

How do I buy shares of Titan Medical?

Shares of TMDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Titan Medical's stock price today?

One share of TMDI stock can currently be purchased for approximately $1.19.

How big of a company is Titan Medical?

Titan Medical has a market capitalization of $97.09 million. Titan Medical employs 9 workers across the globe.

What is Titan Medical's official website?

The official website for Titan Medical is www.titanmedicalinc.com.

How can I contact Titan Medical?

Titan Medical's mailing address is 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7. The company can be reached via phone at 416-548-7522.

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.